An official website of the United States government
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.
When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.
Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.
Summary: This SPA reflects the transition of the Drug Medi-Cal program functions from the Department of Alcohol and Drug programs to the Department of Health Care Services (DHCS).
Summary: Removes the provision of an additional unit dose dispensing fee of $5.00 per recipient per month, and to remove text related to the prescription threshold limits that will be a function of the preauthorization process.
Summary: This SPA allows the state to negotiate supplemental rebates for Medicaid covered outpatient prescription drugs to Mississippi beneficiaries using the Mississippi Medicaid Supplemental Drug Rebate Agreement and the Sovereign States Drug Addendum to the Member States' Agreements.
Summary: This amendment will discontinue the pharmacy Opt-In program, which requires recipients receiving more that eleven prescriptions per month to remain at one pharmacy.
Summary: The plan amendment updates the state plan to comply with the change in the law, which requires Part D drug coverage of barbiturates used in the treatment of epilepsy, cancer, or a chronic mental health disorder and benzodiazepines.
Summary: This SPA discontinue coverage of legend (prescription only) brand and generic agents used for symptomatic relief of cough and cold. The Agency will continue to cover certain over-the-counter (OTC) cough and cold products in an effort to provide cost effective alternatives to recipients.
